CoChat

ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis

Open access

The DOI matches its Crossref record; 128 of the 130 references it cites were found in a registry or an index.

Abstract

Background: Allergy is a form of immune-mediated exaggerated sensitivity (hypersensitivity) to a substance that is either inhaled, swallowed, injected or comes into contact with the skin. Foreign substances that provoke allergies are called allergens. It has been claimed that multiplex allergen testing may help in diagnosing the cause of symptoms in patients with an unclear cause of allergy or who are allergic to more than one substance. Objectives: To evaluate multiplex allergen testing [devices that can measure the presence of multiple immunoglobulin E (IgE) antibodies in a patient’s blood at the same time], by assessing (1) clinical effectiveness (allergy symptoms, incidence of acute exacerbations, mortality, adverse events of testing and treatment, health-care presentations or admissions, health-related quality of life); (2) effects on treatment (diet, immunotherapy medications, other potential testing); (3) any additional diagnostic information provided by multiplex allergen testing; and (4) cost-effectiveness (cost of different assessment strategies). Methods: Fifteen databases were searched from 2005 to April 2015, including MEDLINE (via OvidSp), MEDLINE In-Process Citations, MEDLINE Daily Update, PubMed (National Library of Medicine), EMBASE, Cochrane Database of Systematic Reviews (CDSR), Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews of Effects (DARE), Health Technology Assessment (HTA) database, Science Citation Index (SCI), Conference Proceedings Citation Index-Science (CPCI-S), BIOSIS Previews, Latin American and Caribbean Health Sciences Literature (LILACS), National Institute for Health Research (NIHR) HTA programme, and the US Food and Drug Administration (FDA); supplementary searches of conference proceedings and trials registries were performed. Review methods followed published guidance from the Cochrane Collaboration and the Centre for Reviews and Dissemination, University of York, UK. The methodological quality of included studies was assessed using appropriate published tools or a review-specific tool designed by the project team. Studies were summarised in a narrative synthesis. Owing to a lack of data on the clinical effectiveness of multiplex allergen testing, no long-term cost-effectiveness model was developed. A conceptual model structure was developed and cost analyses were performed to examine the short-term costs of various possible diagnostic pathways. Results: Fifteen studies were included in the review. The very limited available data indicated that the addition of multiplex allergen testing [ImmunoCAP®Immuno Solid-phase Allergen Chip (ISAC), Thermo Fisher Scientific/Phadia AB, Uppsala, Sweden] to standard diagnostic work-up can change the clinicians’ views on the diagnosis, management and treatment of patients. There was some indication that the use of ImmunoCAP ISAC testing may be useful to guide decisions on the discontinuation of restrictive diets, the content of allergen-specific immunotherapy (SIT) prescriptions, and whether or not patients should receive SIT. However, none of the studies that we identified reported any information on clinical outcomes subsequent to changes in treatment or management. There was some evidence that ImmunoCAP ISAC may be useful for discriminating allergens that are structurally similar and are recognised by the same IgE antibody (cross-immunoreactive). No data were available for Microtest (Microtest Matrices Ltd, London, UK). Detailed cost analyses suggested that multiplex allergen testing would have to result in a substantial reduction of the proportions of patients receiving single IgE testing and oral food challenge tests in order to be cost-saving in the short term. Conclusions: No recommendations for service provision can be made based on the analyses included in this report. It is suggested that a consensus-based protocol for the use of multiplex allergen testing be developed. The clinical effectiveness and cost-effectiveness of the proposed protocol should then be assessed by comparing long-term clinical and quality of life outcomes and resource use in patients managed using the protocol with those managed using a standard diagnostic pathway. Study registration: This study is registered as PROSPERO CRD42015019739. Funding: This project was a Diagnostic Assessment Report commissioned by the NIHR HTA programme on behalf of the National Institute for Health and Care Excellence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3310/hta20670

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 90

  1. Allergy UK, 2014, Allergy Statistics
  2. Hippisley-Cox, 2007, A Description of the Fourth version of the QRESEARCH Database: an analysis using QRESEARCH for the Department of Health.
  3. Hippisley-Cox, 2007, Primary Care Epidemiology of Allergic Disorders: Analysis Using QRESEARCH Database 2001–6: Final Report to the Information Centre and Department of Health
  4. National Institute for Health and Care Excellence, 2011, Food Allergy in Children and Young People: Diagnosis and Assessment of Food Allergy in Children and Young People in Primary Care and Community setTings
  5. Health and Social Care information Centre (HSCIC), 2015, NHS Accident and Emergency Attendances in England 2013–14: Tables
  6. National Institute for Health and Care Excellence, 2011, Anaphylaxis: Assessment to Confirm an Anaphylactic Episode and the Decision to Refer After Emergency Treatment for a Suspected Anaphylactic Episode
  7. National Institute for Health and Care Excellence, 2013, Atopic Eczema in Under 12s
  8. National Institute for Health and Care Excellence, 2007, Atopic Eczema in Under 12s: Diagnosis and Management
  9. Royal College of Physicians (RCP), 2003, Allergy: The Unmet Need: A Blueprint for Better Patient Care
  10. Allergy, 2003, Stolen Lives – The Allergy Report: the Impact of Allergies on People’s Lives in the UK Today
  11. Allergy, 2013, The Disturbing Impact of Skin Allergy and Sensitivity in the UK
  12. National Institute for Health and Care Excellence, 2011, Diagnostics Assessment Programme Manual
  13. Canadian Agency for Drugs and Technologies in Health (CADTH), 2013, CADTH Peer Review Checklist for Search Strategies
  14. Critical Appraisal Skills Programme (CASP), 2013, 12 Questions to Help You Make Sense of a Cohort Study
  15. Landivar Encalada, 2012, How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex area of pollen sensitisation (Madrid, Spain). Proceedings of the European Academy of Allergy and Clinical Immunology, 31st Congress, 16–20 June 2012, Geneva, Switzerland, Allergy, 67, 30
  16. Hermansson, 2014, Health economic benefit of including component resolved diagnostics (ImmunoCAP ISAC) in in vitro diagnostics algorithm in a prospective trial with suspected food allergic school children in Finland. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 8
  17. Heaps, 2010, The assessment of an immuno solid-phase allergen chip in the investigation of idiopathic anaphylaxis. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 96
  18. Gay-Crosier, 2010, Allergen-specific IgE levels and IgE/IgG4-ratios measured by microarray technique (ISAC) reflect the clinical response to subcutaneous immunotherapy (SIT). Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 29
  19. Luengo, 2010, Structured assessment of component resolved diagnosis using a immunoassay platform for multiplex measurement of sIgE in multi-sensitised allergic patients. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 743
  20. Noimark, 2012, ISAC allows greater understanding of the food allergy profile in children with moderate to severe eczema. Proceedings of the British Society for Allergy and Clinical Immunology, 2012 Annual Meeting, 2–4 July 2012, Nottingham, UK, Clin Exp Allergy, 42, 1848
  21. Sokolova, 2009, [Immuno solid-phase allergen chip microarray for evaluation of cow’s milk proteins’ sensitisation profile], Revista Portuguesa de Imunoalergologia, 17, 325
  22. Abe, 2012, Allergen analysis by component-resolved diagnostics (CRD) in patients with oral allergy syndrome, J Tokyo Med Univ, 70, 196
  23. Passalacqua, 2013, The additional values of microarray allergen assay in the management of polysensitised patients with respiratory allergy. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 88
  24. Mascialino, 2013, Is the usage of molecular allergology diagnostics for allergen-specific immunotherapy indication in complex pollen areas cost-effective? Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 131
  25. Rodriguez-Ferran, 2011, Screening respiratory allergy in children in primary care: which test should we use? Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 198
  26. Egert-Schmidt, 2014, Subcutaneous allergen immunotherapy with high-dose hypoallergenic pollen preparations improves quality of life and is effective and safe in real life, Allergy, 69, 403
  27. NHS Choices, 2014, Allergies – Diagnosis
  28. National Institute for Health and Care Excellence (NICE), 2011, Food Allergy in Children and Young People: Costing Report
  29. Curtis, 2014, Unit Costs of Health and Social Care 2014
  30. Department of Health (DH), 2015, NHS Reference Costs 2013 to 2014
  31. Thermo Scientific, 2012, Frontline Biochip Technology – Features and Benefits in Allergy Diagnostics
  32. Sanz, 2010, Sensitivity and specificity for three mediterranean pollen allergen components in ISAC microarray CRD103 technology. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 95
  33. Acosta Rivera, 2012, Component resolved diagnosis in children with nut allergy. Proceedings of the European Academy of Allergy and Clinical Immunology, 31st Congress, 16–20 June 2012, Geneva, Switzerland, Allergy, 67, 509
  34. Alessandri, 2011, Predicting tolerability to boiled egg by means of hen’s egg allergen IgE detection by ISAC. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 224
  35. Alonso, 2014, Prevalence of nut allergy in Spain and diagnostic capacity of specific IgE by microarray. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 300
  36. Alvarado, 2013, Sensitisation profiles and clinical relevance of food allergy in patients sensitised to profilin. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 412
  37. Blankestijn, 2014, Evaluation of patients with food allergy with the help of the ImmunoCAP ISAC, Ned Tijdschrift Dermatol Venereol, 24, 259
  38. Bonini, 2010, Array-based molecular diagnostics in multi-sensitised adults with respiratory symptoms. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 54
  39. Caimmi, 2011, Microarray test and peanut allergy. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 145
  40. Caimmi, 2011, The use of microarray in the diagnosis of allergy in pediatrics. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 332
  41. Caimmi, 2013, Usefulness of molecular diagnosis. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 311
  42. Carter, 2012, Identification of clinically relevant allergens using the Phadia ISAC microarray in patients with idiopathic anaphylaxis. Proceedings of the British Society for Allergy and Clinical Immunology, 2012 Annual Meeting, 2–4 July 2012, Nottingham, UK, Clin Exp Allergy, 42, 1829
  43. Cavagni, 2010, Utility in clinical practice of a component-based allergen-microarray in food allergy practice. Proceedings of the American College of Allergy, Asthma and Immunology, 2010 Annual Meeting, 11–16 November 2010, Phoenix, Arizona, USA, Ann Allergy Asthma Immunol, 105, A34
  44. Chambel, 2011, Polysensitisation to pollens analyzed and reinterpreted with the microarray technique. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 521
  45. Charalambous, 2014, Is component-resolved diagnostics and ImmunoCAP ISAC assay useful in the management of paediatric allergy patients in a tertiary clinic? Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 176
  46. Choi, 2014, Diagnostic efficacy of microarray-based specific IgE assay in atopic dermatitis. Proceedings of the Korean Dermatological Association, 3rd Eastern Asia Dermatology Congress, 24–6 Sept 2014, Jeju, South Korea, J Dermatol, 41, 73
  47. De Amici, 2014, Clinical comparison between previous and new ISAC test kit. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 304
  48. De Boer, 2012, Analytical validation of immuno solid-phase allergen chip; limit of detection vs limit of reporting. Proceedings of the European Academy of Allergy and Clinical Immunology, 31st Congress, 16–20 June 2012, Geneva, Switzerland, Allergy, 67, 31
  49. De Boer, 2013, Component resolved diagnosis: recording of discrepancies between single and multiplex IgE analysis. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22–26 June 2013, Milan, Italy, Allergy, 68, 305
  50. Doyen, 2011, Omalizumab did not modify component resolved diagnosis in severe asthma. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 331
  51. Fernandez, 2011, Comparison of molecular allergens by two methods in allergy patients of a Mediterranean area. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 330
  52. Flores, 2014, Comparison of specific IgE and molecular allergens in patients of the Mediterranean area. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 207
  53. Fung, 2012, Microarray component testing in association with IgE mediated food allergy: a retrospective analysis assessing performance of multiple versus individual components. Proceedings of the American College of Allergy, Asthma and Immunology, 2012 Annual Meeting, 8–13 November 2012, Anaheim, CA, USA, Ann Allergy Asthma Immunol, 109, A31
  54. Gadisseur, 2009, A new diagnostic tool for in vitro allergy. Proceedings of the European Academy of Allergy and Clinical Immunology, 28th Congress, 6–10 June 2009, Warszawa, Poland, Allergy, 64, 30
  55. Gadisseur, 2012, Allergen microarrays and their utility in routine clinical practice. Proceedings of the European Academy of Allergy and Clinical Immunology, 31st Congress, 16–20 June 2012, Geneva, Switzerland, Allergy, 67, 31
  56. Garriga Baraut, 2010, RECORD study: recombinant allergens in diagnostic resolution in poly-pollen sensitised patients from Barcelona. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 95
  57. Jung, 2012, Utility of component-based allergen chip (ImmunoCAP ISAC) in diagnosis of allergic rhinitis. Presented at 22nd World Allergy Congress, 4–8 November 2011, Cancun, Mexico, World Allergy Organ J, 5, S196
  58. Kattan, 2013, The use of the ISAC microarray platform in food allergic. Proceedings of the American Academy of Allergy, Asthma and Immunology, 2013 Annual Meeting (AAAAI 2013), 22–6 February 2013, San Antonio, TX, USA, J Allergy Clin Immunol, 131
  59. Konradsen, 2015, Evaluation of Microtest allergy system compared to three established diagnostic methods, Allergy, 70, S173
  60. Lee, 2013, Clinical and immunological characteristics in children with walnut allergy. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 414
  61. Liso, 2011, Total IgE detected on a microarray-based system using spotted omalizumab as anti-IgE. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 140
  62. Liu, 2011, Component-resolved diagnostics with Ara h 2 predictive of peanut allergy in children and adults. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 77
  63. Lohman, 2013, Simultaneous detection of total and allergen-specific immunoglobulin-E in human plasma using multiplex array technology. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 313
  64. Luengo, 2011, Component resolved diagnosis using an immunoassay platform for multiplex measurement of sIgE in multi-sensitised allergic patients. Proceedings of the American Academy of Allergy, Asthma and Immunology, 2011 AAAAI Annual Meeting, 18–22 March 2011, San Francisco, CA, USA, J Allergy Clin Immunol, 127, AB163
  65. Mailhol, 2013, Plant food allergy exploration in adults: micro arrayed-based component-resolved diagnosis. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 415
  66. Martinez-Aranguren, 2013, Reproducibility analysis of multiplex IgE analysis. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 306
  67. Confidential information has been removed
  68. Murng, 2011, A study of ISAC (Immuno Solid-phase Allergen Chip) assay performance and interpretation. Proceedings of the British Society for Allergy and Clinical Immunology, 2011 Annual Meeting (BSACI 2011), 11–13 July 2011, Nottingham, UK, Clin Exp Allergy, 41, 1839
  69. Murng, 2011, Validation of immunoCAP ISAC assay performance. Proceedings of the British Society for Immunology, Annual Congress 2011, 2–8 December 2011, Liverpool, UK, Immunology, 135, 73
  70. Nicaise-Rolland, 2010, Microarray-based IgE detection improves the diagnosis of allergic asthma. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 95
  71. Nystrand, 2012, Evaluation of a new version of a microarray immunoassay for detection of allergen component specific IgE antibodies. Proceedings of the European Academy of Allergy and Clinical Immunology, 31st Congress, 16–20 June 2012, Geneva, Switzerland, Allergy, 67, 31
  72. Olivieri, 2010, IgE profiling using new wheat-derived allergens and ISAC 103 microarray in bakers with occupational allergic respiratory disease. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 57
  73. Paes, 2010, Peach allergy: sensitisation profile by component resolved diagnosis microarray. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 29th Congress, 5–9 June 2010, London, UK, Allergy, 65, 412
  74. Palomba, 2013, External Evaluation of Microtest Performance. PDF provided by company, Microtest Dx Technical Bulletin, 1, 1
  75. Palomba, 2014, Evaluation of a new microarray based system for allergy testing. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 9
  76. Sanchez-Lopez, 2013, Sensitisation to Act d 2 in patients allergic to Alternaria alternata: an epiphenomenon without clinical significance? Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 303
  77. Santos, 2011, IgE cross-reactivity to tropomyosins among patients with asthma and/or rhinitis from Brazil: analysis by component-based Allergen microarray. Proceedings of the American Academy of Allergy, Asthma and Immunology, 2011 AAAAI Annual Meeting, 18–22 March 2011, San Francisco, CA, USA, J Allergy Clin Immunol, 127
  78. Sastre, 2014, Molecular diagnosis may help to predict adverse reactions to immunotherapy in Spanish grass allergic patients. Proceedings of the European Academy of Allergy and Clinical Immunology, 33rd Congress, 7–11 June 2014, Copenhagen, Denmark, Allergy, 69, 72
  79. Scala, 2011, The lesson from Anisakis simplex sensitisation: the need for a molecular approach. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 388
  80. Scala, 2011, Allergenic molecule-based microarray-based allergy diagnosis: the second ‘real life’ study on a cohort of 23559 subjects. Proceedings of the European Academy of Allergy and Clinical Immunology (EAACI), 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 100
  81. Seyfarth, 2011, Detection of latex sensitizations using CAST, Western Blot, ImmunoCAP (R), and ISAC (R). Proceedings of der Deutschen Dermatologischen Gesellschaft, 46. Tagung Vereinigung Deutschsprachiger Dermatologen e. V, 30 March–2 April 2011, Dresden, Germany, J Dtsch Dermatol Ges, 9, 167
  82. Seyfarth, 2011, Diagnosing latex sensitizations with recombinant latex allergens: the Immunosolid-phase allergen chip (ISAC). Proceedings of the Arbeitsgemeinschaft Dermatologische Forschung, 38th Annual Meeting, ADF 2011, 17–19 February 2011, Tuebingen, Germany, Exp Dermatol, 20, 163
  83. Sousa, 2009, Comparison between skin prick tests and ImmunoCAP ISACR in the determination of sensitisation to aeroallergens. Proceedings of the European Academy of Allergy and Clinical Immunology, 28th Congress, 6–10 June 2009, Warsaw, Poland, Allergy, 64, 273
  84. Tolkki, 2013, Clinical and IgE profiling of birch (Betula verrucosa) allergic individuals suffering from allergic reactions to raw fruits and vegetables. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 307
  85. Tripathi, 2012, Investigation of eosinophilic esophagitis in adults using skin testing, ImmunoCAP, and ImmunoCAP ISAC IgE quantitation, Ann Allergy Asthma Immunol, 109, A3
  86. Tripathi, 2014, Challenges with measurement of IgE antibodies in eosinophilic esophagitis, peanut allergy, and mammalian meat allergy. Proceedings of the American College of Allergy, Asthma and Immunology, 2014 Annual Meeting, 6–10 November 2014, Atlanta, GA, USA, Ann Allergy Asthma Immunol, 113, A16
  87. Uriarte, 2013, Molecular diagnosis in dog allergy. Proceedings of the European Academy of Allergy and Clinical Immunology and World Allergy Organization, World Allergy and Asthma Congress 2013, 22 June 2013, Milan, Italy, Allergy, 68, 312
  88. Weimann, 2011, Component-resolved multiparameter assays for the diagnosis of birch pollen and grass pollen allergy. Proceedings of the European Academy of Allergy and Clinical Immunology, 30th Congress, 11–15 June 2011, Istanbul, Turkey, Allergy, 66, 721
  89. Confidential information has been removed
  90. Young, 2012, The utility of ISAC (immuno solid-phase allergen chip) in identifying clinically relevant IgE reactivity in patients with atopic dermatitis. Proceedings of the British Society for Allergy and Clinical Immunology, 2012 Annual Meeting, 2–4 July 2012, Nottingham, UK, Clin Exp Allergy, 42, 1838

Cited by

See all 49

Metadata

Authors
Westwood, M., Ramaekers, B., Lang, S., Armstrong, N., Noake, C., de Kock, S., Joore, M., Severens, J., & Kleijnen, J.
Affiliations
  • Kleijnen Systematic Reviews (United Kingdom) (GB)
  • Maastricht University Medical Centre (NL)
  • Kleijnen Systematic Reviews Ltd, York, UK
  • Erasmus University Rotterdam (NL)
  • Maastricht University (NL)
Corresponding author
Westwood, Marie
Venue
Health Technology Assessment
Published
2016-09
Volume
20
Issue
67
Pages
1-178
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
OpenAlex
W2520843177
Cited by
49
References
130
Citations by year
2026: 2 · 2025: 5 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 3 · 2018: 6 · 2017: 3
FWCI
0.60
Type
journal article
Language
en
Open access
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Bristol Research (University of Bristol) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
Health Technology Assessment programme (14/69/06)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
specific IgE, allergic diseases, cost-effectiveness, diagnostic pathway, allergic rhinitis, allergic asthma, allergic conjunctivitis, allergic dermatitis, immunotherapy, health-related quality of life, health care costs
MeSH terms
Allergens, Cost-Benefit Analysis, Diet, United Kingdom, Humans, Hypersensitivity, Immunoglobulin E, Immunologic Tests, Immunotherapy, Technology Assessment, Biomedical, Models, Econometric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.